US Patent 10253067 Peptidomimetic macrocycles and uses thereof
Patent 10253067 was granted and assigned to Aileron Therapeutics on April, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+273 characters)
Article
Patent abstract
Methods for treating liquid cancer, determined to lack a p53 deactivation mutation, in a subject are provided. Also provided are peptidomimetic macrocycles for use in treatment of a liquid cancer, determined to lack a p53 deactivation mutation, in a subject.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Chris Viau0
David Allen Annis0
Hubert Chen0
Karen Olson0
Manuel Aivado0
Yong Chang0
Edits on 25 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10253067 Peptidomimetic macrocycles and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10253067
Date of patent
April 9, 2019
Patent application number
15074794
Date Filed
March 18, 2016
Patent primary examiner
Find more entities like US Patent 10253067 Peptidomimetic macrocycles and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.